Your browser doesn't support javascript.
loading
Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 national immunization survey-teen.
Stokley, Shannon; Cohn, Amanda; Jain, Nidhi; McCauley, Mary M.
Afiliación
  • Stokley S; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. sstokley@cdc.gov
Arch Pediatr Adolesc Med ; 165(9): 813-8, 2011 Sep.
Article en En | MEDLINE | ID: mdl-21893647
OBJECTIVES: To determine vaccination coverage at selected ages and by birth cohort and to assess whether all indicated vaccines were administered during vaccination visits. DESIGN: Population-based cross-sectional study. SETTING: National Immunization Survey-Teen 2009 telephone interview. PARTICIPANTS: United States adolescents aged 13 to 17 years with provider-reported vaccination histories (N = 20 066). MAIN OUTCOME MEASURES: Among all adolescents and by birth cohort: coverage estimates for 3 childhood vaccines (measles-containing, hepatitis B, and varicella) and 3 adolescent vaccines (tetanus-diphtheria and/or tetanus-diphtheria-acellular pertussis, meningococcal-containing, and human papillomavirus for girls) at selected ages. RESULTS: By age 11 years, most adolescents had obtained the childhood vaccines. Receipt of a tetanus-diphtheria and/or tetanus-diphtheria-acellular pertussis vaccine at ages 11 to 12 years increased significantly from the 1991 to 1996 birth cohort (33.8% vs 68.2%, P < .001); receipt of meningococcal-containing vaccine at ages 11 to 12 years increased significantly from the 1993 to 1996 birth cohort (8.4% vs 50.0%, P < .001). Among girls, receipt of human papillomavirus vaccine at ages 11 to 12 years increased significantly from the 1994 to 1996 birth cohort (11.1% vs 30.5%, P < .001). Overall, 54.9% of adolescents received at least 1 vaccination visit at ages 11 to 12 years. Among adolescents who made a vaccination visit at ages 11 to 12 years and were eligible for vaccination, 19.5% did not receive tetanus-diphtheria and/or tetanus-diphtheria-acellular pertussis, 60.9% did not receive meningococcal-containing, and 62.4% did not receive human papillomavirus vaccines. CONCLUSIONS: Receipt of vaccines at the recommended ages of 11 to 12 years appears to be increasing; however, providers often do not administer all indicated vaccines during a vaccination visit.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cooperación del Paciente / Vacunación Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Arch Pediatr Adolesc Med Asunto de la revista: PEDIATRIA Año: 2011 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cooperación del Paciente / Vacunación Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Child / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Arch Pediatr Adolesc Med Asunto de la revista: PEDIATRIA Año: 2011 Tipo del documento: Article País de afiliación: Estados Unidos